These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 33515024)

  • 1. HCC subtypes based on the activity changes of immunologic and hallmark gene sets in tumor and nontumor tissues.
    Gong J; Li R; Chen Y; Zhuo Z; Chen S; Cao J; Zhang Q; Chong Y; Hu B
    Brief Bioinform; 2021 Sep; 22(5):. PubMed ID: 33515024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of Novel Subtypes in Lung Adenocarcinoma: Evidence from Gene Set Variation Analysis in Tumor and Adjacent Nontumor Samples.
    Li F; Wan B; He X; Li X
    Dis Markers; 2022; 2022():2602812. PubMed ID: 35096200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Ribosome-Related Prognostic Signature of Breast Cancer Subtypes Based on Changes in Breast Cancer Patients' Immunological Activity.
    Luan T; Song D; Liu J; Wei Y; Feng R; Wang X; Gan L; Wan J; Fang H; Li H; Gong X
    Medicina (Kaunas); 2023 Feb; 59(3):. PubMed ID: 36984424
    [No Abstract]   [Full Text] [Related]  

  • 4. Head and Neck Squamous Cell Carcinoma Subtypes Based on Immunologic and Hallmark Gene Sets in Tumor and Non-tumor Tissues.
    Yin J; He X; Xia H; He L; Li D; Hu L; Zheng S; Huang Y; Li S; Hu W
    Front Surg; 2022; 9():821600. PubMed ID: 35187059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of disease-free survival in hepatocellular carcinoma by gene expression profiling.
    Lim HY; Sohn I; Deng S; Lee J; Jung SH; Mao M; Xu J; Wang K; Shi S; Joh JW; Choi YL; Park CK
    Ann Surg Oncol; 2013 Nov; 20(12):3747-53. PubMed ID: 23800896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Construction and Validation of a Prognostic Gene-Based Model for Overall Survival Prediction in Hepatocellular Carcinoma Using an Integrated Statistical and Bioinformatic Approach.
    Dessie EY; Tu SJ; Chiang HS; Tsai JJP; Chang YS; Chang JG; Ng KL
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33562824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a five-immune gene model as an independent prognostic factor in hepatocellular carcinoma.
    Chen H; Li Y; Xiao SY; Guo J
    BMC Cancer; 2021 Mar; 21(1):278. PubMed ID: 33726698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Construction of a risk score prognosis model based on hepatocellular carcinoma microenvironment.
    Zhang FP; Huang YP; Luo WX; Deng WY; Liu CQ; Xu LB; Liu C
    World J Gastroenterol; 2020 Jan; 26(2):134-153. PubMed ID: 31969776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combining clinical, pathology, and gene expression data to predict recurrence of hepatocellular carcinoma.
    Villanueva A; Hoshida Y; Battiston C; Tovar V; Sia D; Alsinet C; Cornella H; Liberzon A; Kobayashi M; Kumada H; Thung SN; Bruix J; Newell P; April C; Fan JB; Roayaie S; Mazzaferro V; Schwartz ME; Llovet JM
    Gastroenterology; 2011 May; 140(5):1501-12.e2. PubMed ID: 21320499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic analysis of tumor mutation burden and immune infiltration in hepatocellular carcinoma based on TCGA data.
    Liu S; Tang Q; Huang J; Zhan M; Zhao W; Yang X; Li Y; Qiu L; Zhang F; Lu L; He X
    Aging (Albany NY); 2021 Apr; 13(8):11257-11280. PubMed ID: 33820866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA CSMD1-1 promotes the progression of Hepatocellular Carcinoma by activating MYC signaling.
    Liu J; Xu R; Mai SJ; Ma YS; Zhang MY; Cao PS; Weng NQ; Wang RQ; Cao D; Wei W; Guo RP; Zhang YJ; Xu L; Chen MS; Zhang HZ; Huang L; Fu D; Wang HY
    Theranostics; 2020; 10(17):7527-7544. PubMed ID: 32685003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of Specific Cervical Cancer Subtypes and Prognostic Gene Sets in Tumor and Nontumor Tissues Based on GSVA Analysis.
    Zhong Z; Wang Y; Yin J; Ni S; Liu W; Geng R; Liu J; Bai J; Yu H
    J Oncol; 2022; 2022():6951885. PubMed ID: 36284631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma.
    Gu JX; Zhang X; Miao RC; Xiang XH; Fu YN; Zhang JY; Liu C; Qu K
    World J Gastroenterol; 2019 Jan; 25(2):220-232. PubMed ID: 30670911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of hepatocellular carcinoma prognostic markers based on 10-immune gene signature.
    Zhao K; Xu L; Li F; Ao J; Jiang G; Shi R; Chen F; Luo Q
    Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32789471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel focal adhesion related gene signature for prognostic prediction in hepatocellular carcinoma.
    Lin Z; Miao D; Xu Q; Wang X; Yu F
    Aging (Albany NY); 2021 Apr; 13(7):10724-10748. PubMed ID: 33850056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carcinogenesis effects of E2F transcription factor 8 (E2F8) in hepatocellular carcinoma outcomes: an integrated bioinformatic report.
    Lü Y; Zhang J; Li L; Li S; Yang Z
    Biosci Rep; 2020 Feb; 40(2):. PubMed ID: 31990034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrated analysis of methylation-driven genes and pretreatment prognostic factors in patients with hepatocellular carcinoma.
    He D; Liao S; Cai L; Huang W; Xie X; You M
    BMC Cancer; 2021 May; 21(1):599. PubMed ID: 34034705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TCGA and ESTIMATE data mining to identify potential prognostic biomarkers in HCC patients.
    He G; Fu S; Li Y; Li T; Mei P; Feng L; Cai L; Cheng Y; Zhou C; Tang Y; Huang W; Liu H; Cen B; Pan M; Gao Y
    Aging (Albany NY); 2020 Nov; 12(21):21544-21558. PubMed ID: 33177245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and validation of redox-immune based prognostic signature for hepatocellular carcinoma.
    Tu K; Li J; Mo H; Xian Y; Xu Q; Xiao X
    Int J Med Sci; 2021; 18(9):2030-2041. PubMed ID: 33850474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of prognostic markers for hepatocellular carcinoma based on the epithelial-mesenchymal transition-related gene BIRC5.
    Xu R; Lin L; Zhang B; Wang J; Zhao F; Liu X; Li Y; Li Y
    BMC Cancer; 2021 Jun; 21(1):687. PubMed ID: 34112092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.